Vitamin D valuable supplement for improving glycemic control in diabetes patients

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-02-03 06:00 GMT   |   Update On 2023-02-03 10:58 GMT
Advertisement

Afghanistan: According to a study published in BMC Endocrine Disorders, Vitamin D supplementation might reduce FPG, HbA1c, and HOMA-IR in type 2 diabetes patients with low vitamin D status.

Vitamin D has potential extra skeletal outcomes in diabetes and many other diseases. Some hypotheses state its anti-diabetic properties while it may have an essential role in glucose homeostasis.

The question is, Is there any role of Vitamin D in people with diabetes for glycemic control? The evidence remains conflicting in this context.

Advertisement

Mohammad Ashraf Farahmand and colleagues from Tehran University of Medical Sciences have assessed the role of Vitamin D supplementation in type 2 diabetes (T2D) patients. The indicators of glycemic control were fasting plasma glucose (FPG), HbA1c, and homeostasis model assessment insulin resistance (HOMA-IR).

The researchers collected data from electronic databases like PubMed/Medline, Web of Science, Embase, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), and NIH’s Clinical Trials Registry.

The study summary includes the following:

  • The study included a meta-analysis having 46 RCTs.
  • The RCTs had 2164 intervention subjects and 2149 placebo controls.
  • There was a significant change in pooled analyses for HbA1c between the two groups. The weighted mean difference (WMD) was -0.20%.
  • After Analysing Fasting Plasma Glucose, a significant reduction was noted in the intervention group with WMD of -5.02 mg/dl after Vitamin D supplementation.
  • Pooled analysis results for HOMA-IR revealed a significant change between the two groups with -0.42.
  • As shown in subgroup analyses, the most efficacy was in a higher dose, short intervention period and in patients who had a deficiency of vitamin D.

To conclude, Vitamin D supplementation is beneficial for T2D patients because it reduces FPG, HbA1c, and HOMA-IR in patients with deficient vitamin D status.

The researchers added that the effect is prominent when vitamin D is given in large doses and for a short time.

Further reading:

Farahmand, M.A., Daneshzad, E., Fung, T.T. et al. What is the impact of vitamin D supplementation on glycemic control in people with type-2 diabetes: a systematic review and meta-analysis of randomized controlled trials. BMC Endocr Disord 23, 15 (2023). https://doi.org/10.1186/s12902-022-01209-x

Tags:    
Article Source : BMC Endocrine Disorders

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News